Research.Patient.info
Chronic Myelomonocytic Leukemia research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE2
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
This study looks at treating certain blood cancers with a drug called azacitidine. Researchers want to see if adding lenalidomide or vorinostat makes azacitidine work better. It’s for adults with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML).
United States · Canada - recruitingPHASE1
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
This study is testing a new drug, APL-4098, alone and with other medicines, for adults with certain types of blood cancers like Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS). Doctors want to see if it's safe, how well it's tolerated, and if it helps.
Australia · United Kingdom